Educate the brightest and best experts in Synthetic Biology about your business: what it is, what it does and why it matters.
Exhibition Sold Out!
The exhibition will be situated at the nucleus of event activity – just outside the conference presentation rooms, an area designed to be at the core of meeting and networking activity.
Don't miss the 'Biodesign Here Now' exhibition at SynbiTECH 2019. This exhibition showcases 17 selected projects to give a first taste of what the field of Biodesign will be able to contribute - from sustainable pollination to grown fashion to personal diagnostics. Find out more at http://www.opencell.bio/synbitech-2019.
CAS is the Scientific Solutions Division of the American Chemical Society. The CAS team of highly trained scientists finds, collects and organises all publicly disclosed substance information, creating the world’s most valuable collection of content. We offer market leading products like SciFinder-n and STN and solutions tailored to your specific needs.
Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. The team of scientists works in different academic partner laboratories and R&D programs involve partners from Belgium, Brazil, France, Germany, The Netherlands, and the UK. Syngulon owns a collection of natural and synthetic bacteriocins. Syngulon is generating a patent portfolio of genetic technologies to solve key issues: Gene containment, Yield increase, Contamination prevention, Genetic drift and Antibiotic-free selection of expressing clone
GenScript is the world leader in biotechnology reagent service industry that provides life sciences services and products to 200,000 scientists in over 100 countries worldwide. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and successfully establish fully-integrated capabilities for custom peptide synthesis, protein expression and engineering, custom antibody development and engineering, synthetic biology, in vitro/in vivo pharmacology as well as a variety of catalogue products, industrial enzymes and microbial reagents.
After almost two decades of fast growth in developing biological reagents, in recent years the company has expanded its business into immunotherapy, CDMO, laboratory equipment and microbial industry to further fulfil its mission in making people and nature healthier through biotechnology. GenScript has also established open and innovative technology-driven platforms and GMP facilities for pre-clinical drugs discovery and pharmaceutical products development along with a completed industrial microbial research, development and industrialization platform for enzyme screening, genetic engineering, protein engineering, and fermentation process optimization and research application.
With global support from all customers worldwide and more than 2600+ employees, GenScript continues to strive for its vision as the most reliable biotech company in the world to make people and nature healthier.
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next-generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com
Streamline sample storage, identification and handling with AltemisLab™️
Helping customers to map work flows and identify the tools that will realise practical, financial and time saving benefits.
AltemisLab 2D barcoded tubes, barcode readers, de-capping, capping and handling equipment, labelling technology, and lab tools symbolise a new era of efficiency. With AltemisLab you can rest assured that compliance, quality control and manufacturing excellence are unrivalled.
The founders of AltemisLab have been working with 2D barcoded tubes since 2000, when this technology was first used by pharmaceutical companies for compound storage. Using our knowledge and experience we have set out to perfect 2D tube design and we are proud to introduce our AlteTube range of sample storage tubes.
AltemisLab is all about looking for better ways to work.
The automated tube and vial handling systems automate critical sample management tasks, with a wide range of modules to help alleviate bottlenecks and standardise processes. The VolumeCheck™️ provides non-contact volume verification for plates, vials and tubes using ultrasonic technology.
The Knowledge Transfer Network (KTN) links new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From biotechnology to autonomous systems and from energy to design, KTN combines in-depth knowledge in all sectors with the ability to cross boundaries. KTN is a network partner of Innovate UK, helping to deliver UK economic growth.
KTN’s Synthetic Biology team focuses on partnering UK’s growing synthetic biology industry with industrial collaborators, research-base expertise and all relevant stakeholders, enabling cross-sector commercialisation.
As a partner in the KETBIO Biotech transfer project, KTN aims to identify Europe's most innovative results in biotechnology research, including synthetic biology and help to speed up their market uptake.
For detailed information on KTN please visit https://www.ktn-uk.co.uk
The University of Manchester’s, Synthetic Biology Research Centre for Synthetic Biology of Fine and Speciality Chemicals (SYNBIOCHEM), funded by BBSRC/EPSRC aims to develop new faster, more predictable and reliable “greener” routes to fine and speciality chemicals production. The Centre will provide tools, technology platforms and SynBio ‘know-how’ to drive academic discovery and translate new knowledge and processes towards industrial exploitation. The technology will lead to new products and methods for drug development, such as new antibiotics, and agricultural chemicals and new materials for sustainable manufacturing.
Evonetix is set to revolutionise de novo gene synthesis to facilitate the fast-growing and exciting field of synthetic biology. Our unique selling point is driven by high fidelity and parallelisation of gene synthesis. www.evonetix.com
Future BRH is an EPSRC/BBSRC funded programme led by the Hub at the Manchester Institute of Biotechnology at The University of Manchester and expertise at spoke partners institutions at Imperial College London; University of Nottingham; University College London; the UK Catalysis Hub; the Industrial Biotechnology Innovation Centre; and the Centre for Process Integration.
At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. https://twistbioscience.com
BrisSynBio, a BBSRC / EPSRC funded Synthetic Biology Research Centre
BrisSynBio is a multi-disciplinary research centre that focuses on the biomolecular design and engineering aspects of synthetic biology.
BrisSynBio is part of the Bristol BioDesign Institute.
Our overarching aims are to:
- Improve understanding of biological assemblies and processes to points that allow the rational and predictable design and engineering of biological and bio-inspired systems;
- Foster systematic, synthetic-biology approaches to the design and engineering of biological systems across scales from atoms and molecules to cells and tissues;
- Train the next generation of scientists and engineers in these approaches;
- Facilitate the translation of fundamental synthetic-biology research to industry and the clinic.
With over 4,000 products in genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists.
Promega products are used by scientists asking fundamental questions about biological processes and applying scientific knowledge to diagnose and treat diseases, discover new therapeutics and use genetics and DNA testing for human identification.
Promega’s core strengths and emerging technologies include:
- Functional Bioassays for Immune Checkpoint, Fc Effector, Cytokine and T Cell Activation Pathways
- Novel Techniques for Protein-Protein Interaction and Protein Degradation Analysis
- New tools for Endogenous Protein Tagging using CRISPR
- Cell-Based Assays for Measuring Viability, Apoptosis, Metabolism & Epigenetics
- Molecular Biology Products for Cloning, Expression and Amplification
- Manual and Automated Nucleic Acid Purification Platforms
We are the IET and we inspire, inform and influence the global engineering community to engineer a better world. As a diverse home across engineering and technology, we share knowledge that helps make better sense of the world in order to solve the challenges that matter. It’s why we are uniquely placed to champion engineering.
Integrated DNA Technologies, Inc. (IDT) is your Advocate for the Genomics Age. For more than 30 years, IDT's innovative tools and solutions for genomics applications have been driving advances that inspire scientists to dream big and achieve their next breakthroughs.
IDT develops, manufactures, and markets nucleic acid products that support the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. We have a global reach with personalized customer service. https://www.idtdna.com/pages
OpenPlant is a joint initiative between the University of Cambridge, John Innes Centre and the Earlham Institute, funded by the BBSRC and EPSRC as part of the UK Synthetic Biology for Growth programme.
OpenPlant is: (i) developing new tools and methods for plant synthetic biology, (ii) providing mechanisms for open sharing of standardised resources, (iii) applying these tools to world-leading projects in trait development, and (iv) facilitating interdisciplinary exchange, outreach and international development. The initiative promotes interdisciplinary exchange, open technologies and responsible innovation for the improvement of sustainable agriculture and conservation.
Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data.
That's why we started Opentrons.
We make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions. https://www.opentrons.com
The company focuses on microreaction and automated solutions for screening and bioprocess development. Our commercialized products are the BioLector, the BioLector Pro, and the FlowerPlate, which provide an intelligent micro fermentation platform. This proprietary technology empowers the biotechnology, chemical, and pharmaceutical industries to increase the number and the information content of microbial experiments (aerobic, microaerophilic, and strictly anaerobic). It enables customers to conduct experiments with high efficiency and excellent quality in microscale at low costs. With the RoboLector, the company also enables the automated fermentation of the whole bioprocess, with the specific integration of the BioLector tool into a liquid handling system.
BMG LABTECH is a leading global developer and manufacturer of innovative, high-quality, and reliable microplate reader instrumentation. BMG LABTECH has been committed to producing microplate readers for more than twenty-five years. By focusing on the needs of the scientific community, the company’s innovative microplate readers have earned the company the reputation of being a technology leader in the field. BMG LABTECH has developed a wide range of dedicated and multi-mode microplate readers for life sciences applications and high-throughput screening.
We, the Dispendix GmbH, are a spinoff of the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart, Germany — and a part of the CELLINK Group. At IPA, a novel liquid-handling technology called I-DOT (“Immediate-Drop-On-Demand technology”) was developed to establish an efficient, flexible alternative non-contact solution for liquid-handling tasks for nano- to microliter volumes. Our vision is to establish a simple and elegant gold standard in non-contact liquid handling that is affordable for everyone. Our passion for simple and elegant solutions drives our motivation to create robust, reliable and precise solutions for nanoliter dispensing.
The UK Centre for Mammalian Synthetic Biology is a BBSRC/EPSRC/MRC Synthetic Biology Research Centre, hosted by the School of Biological Sciences at the University of Edinburgh. Our vision is to apply synthetic biology in mammalian systems to realise its full potential for human medicine.
With world-leading faculty members drawn from the Biological Sciences, Medicine, Engineering, Informatics and the Social Sciences, the Centre offers an exciting and collaborative research environment. It also embeds colleagues from the Scottish Centre for Regenerative Medicine, a centre of excellence for stem cell research, who are supervisors on several projects.
WISB delivers an integrated, internationally leading programme of research, innovation and training for synthetic biology. WISB is a BBSRC/EPSRC funded Synthetic Biology Research Centre (SBRC), supported through the UK Research Councils' Synthetic Biology for Growth programme.
The SBRC-Nottingham is one of six synthetic biology research centres established by the UK Research councils BBSRC and EPSRC.
Our centre concentrates on engineering bacteria to make industrially-useful products from C1-feedstocks including the greenhouse gases, carbon monoxide and carbon dioxide and methane.
Analytik Jena is a leading manufacturer of analytical measuring technology, Liquid handling and associated Life Science instrumentation and Chemistries supporting many applications including Synthetic Biology. Their renowned CyBio FeliX liquid handling platforms and automation systems are chosen by Synthetic Biology labs worldwide to integrate pipetting and associated tasks from Gene Assembly through Cloning, clean ups and Transformations. Analytik Jena´s products are continually developed to offer customers ease of use, quality and reproducibility of their laboratory results. Quality Service support, as well as device-specific consumables and reagents, complete the product portfolio. Analytik Jena is part of the Endress+Hauser Group.
Eurofins Genomics, with major offices and production sites in Europe, Japan and the USA, is an international provider of genomic services established around the core business lines DNA sequencing, oligonucleotides, siRNA and gene synthesis. The company's main mission is focussed on providing customer convenience and high-quality services in industrial scale for the life science industries and academic research institutions around the world. Eurofins Genomics competence in the synthesis of Oligo’s has made the company a European market leader and a strong global player.
For further information about Eurofins Genomics, please visit www.eurofinsgenomics.com